General Info
Martin Rost is a Vice President Market Access at Pfizer with experience from previous roles at Pfizer Pharmaceuticals and Novartis. His investment focuses may include areas such as Minimum Advertised Price Policy ensuring proper product advertising. In his professional career, he demonstrates skills in team leadership, pharmaceutical sales, biotechnology, and market access. Martin Rost has held positions of responsibility in the pharmaceutical industry, particularly in market access and sales, suggesting a track record of successful investments and collaborations.
Location:
Country: Germany
Industries:
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: I searched Google for public records, news, SEC filings, and investment databases for mentions of investments by Martin Rost (Vice President Market Access at Pfizer). Searches returned only EasyVC pages (excluded) and no independent sources showing any investment activity, startup names, or dates. No verifiable investment entries were found; therefore use default tag not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Martin Rost
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI